Suppr超能文献

从一种波利尼西亚传统植物抗惊厥药中发现一种强效、Kv7.3选择性钾通道开放剂。

Discovery of a potent, Kv7.3-selective potassium channel opener from a Polynesian traditional botanical anticonvulsant.

作者信息

Abbott Geoffrey W, Manville Rían W

机构信息

Bioelectricity Laboratory, Department of Physiology and Biophysics, School of Medicine, University of California, Irvine, CA, USA.

出版信息

Commun Chem. 2024 Oct 10;7(1):233. doi: 10.1038/s42004-024-01318-9.

Abstract

Plants remain an important source of biologically active small molecules with high therapeutic potential. The voltage-gated potassium (Kv) channel formed by Kv7.2/3 (KCNQ2/3) heteromers is a major target for anticonvulsant drug development. Here, we screened 1444 extracts primarily from plants collected in California and the US Virgin Islands, for their ability to activate Kv7.2/3 but not inhibit Kv1.3, to select against tannic acid being the active component. We validated the 7 strongest hits, identified Thespesia populnea (miro, milo, portia tree) as the most promising, then discovered its primary active metabolite to be gentisic acid (GA). GA highly potently activated Kv7.2/3 (EC, 2.8 nM). GA is, uniquely to our knowledge, 100% selective for Kv7.3 versus other Kv7 homomers; it requires S5 residue Kv7.3-W265 for Kv7.2/3 activation, and it ameliorates pentylenetetrazole-induced seizures in mice. Structure-activity studies revealed that the FDA-approved vasoprotective drug calcium dobesilate, a GA analog, is a previously unrecognized Kv7.2/3 channel opener. Also an active aspirin metabolite, GA provides a molecular rationale for the use of T. populnea as an anticonvulsant in Polynesian indigenous medicine and presents novel pharmacological prospects for potent, isoform-selective, therapeutic Kv7 channel activation.

摘要

植物仍然是具有高治疗潜力的生物活性小分子的重要来源。由Kv7.2/3(KCNQ2/3)异源二聚体形成的电压门控钾(Kv)通道是抗惊厥药物开发的主要靶点。在此,我们筛选了1444种主要从加利福尼亚州和美属维尔京群岛采集的植物提取物,以评估它们激活Kv7.2/3而不抑制Kv1.3的能力,以排除单宁酸是活性成分的可能性。我们验证了7个最强活性提取物,确定了杨叶肖槿(米罗、米洛、波西亚树)是最有前景的植物,然后发现其主要活性代谢产物是龙胆酸(GA)。GA能高效激活Kv7.2/3(EC50为2.8 nM)。据我们所知,GA对Kv7.3相对于其他Kv7同型异构体具有100%的选择性;它激活Kv7.2/3需要Kv7.3的S5残基W265,并且它能改善小鼠戊四氮诱导的癫痫发作。构效关系研究表明,FDA批准的血管保护药物羟苯磺酸钙,一种GA类似物,是一种以前未被认识的Kv7.2/3通道开放剂。GA也是一种活性阿司匹林代谢产物,为杨叶肖槿在波利尼西亚本土医学中用作抗惊厥药提供了分子理论依据,并为强效、亚型选择性治疗性Kv7通道激活提供了新的药理学前景。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d790/11467302/90440116320f/42004_2024_1318_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验